These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3264919)

  • 1. Correlation with 3H-MPP+ binding sites by debrisoquin and some analogues in mouse brain.
    Ruju S; Del Zompo M; Piccardi MP; Maggio R; Corsini GU
    Pharmacol Res Commun; 1988 Dec; 20(12):1105-6. PubMed ID: 3264919
    [No Abstract]   [Full Text] [Related]  

  • 2. [3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion binding sites in mouse brain: pharmacological and biological characterization.
    Del Zompo M; Ruiu S; Maggio R; Piccardi MP; Corsini GU
    J Neurochem; 1990 Jun; 54(6):1905-10. PubMed ID: 2338548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity binding sites for 1-methyl-4-phenyl-pyridinium ion (MPP+) are present in mouse brain.
    Del Zompo M; Bernardi F; Maggio R; Piccardi M; Johannessen JN; Corsini GU
    Eur J Pharmacol; 1986 Sep; 129(1-2):87-92. PubMed ID: 3490391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the toxicity of the dopaminergic neurotoxins MPTP and MPP+ in PC12 pheochromocytoma cells: binding and biological studies.
    Marongiu ME; Piccardi MP; Bernardi F; Corsini GU; Del Zompo M
    Neurosci Lett; 1988 Dec; 94(3):349-54. PubMed ID: 3264604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra.
    Langston JW; Irwin I; Langston EB; Forno LS
    Neurosci Lett; 1984 Jul; 48(1):87-92. PubMed ID: 6332288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
    Chiba K; Trevor AJ; Castagnoli N
    Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of rat brain monoamine oxidase by some analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion.
    Arai Y; Kinemuchi H; Hamamichi N; Satoh N; Tadano T; Kisara K
    Neurosci Lett; 1986 May; 66(1):43-8. PubMed ID: 3487053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebral microdialysis neurotoxicity studies of quinoline and isoquinoline derivatives related to MPTP/MPP+.
    Booth RG; Castagnoli N; Rollema H
    Neurosci Lett; 1989 May; 100(1-3):306-12. PubMed ID: 2788253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and biochemical mechanisms involved in MPTP-induced parkinsonism.
    Poirier J
    J Am Geriatr Soc; 1987 Jul; 35(7):660-8. PubMed ID: 3108351
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity.
    Sershen H; Mason MF; Debler EA; Lajtha A
    Eur J Pharmacol; 1986 Jul; 126(3):337-9. PubMed ID: 3489627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity.
    Kinemuchi H; Arai Y; Toyoshima Y
    Neurosci Lett; 1985 Jul; 58(2):195-200. PubMed ID: 3876524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+.
    Shen RS; Abell CW; Gessner W; Brossi A
    FEBS Lett; 1985 Sep; 189(2):225-30. PubMed ID: 3876242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MPTP, MPP+ and mitochondrial function.
    Nicklas WJ; Youngster SK; Kindt MV; Heikkila RE
    Life Sci; 1987 Feb; 40(8):721-9. PubMed ID: 3100899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in lipid peroxidation induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in mouse brain homogenates.
    Ríos C; Tapia R
    Neurosci Lett; 1987 Jun; 77(3):321-6. PubMed ID: 3497366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver.
    Riachi NJ; Harik SI; Kalaria RN; Sayre LM
    J Pharmacol Exp Ther; 1988 Feb; 244(2):443-8. PubMed ID: 3258032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon.
    Schinelli S; Zuddas A; Kopin IJ; Barker JL; di Porzio U
    J Neurochem; 1988 Jun; 50(6):1900-7. PubMed ID: 3259619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Singer TP; Salach JI; Crabtree D
    Biochem Biophys Res Commun; 1985 Mar; 127(2):707-12. PubMed ID: 3872126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+.
    Ransom BR; Kunis DM; Irwin I; Langston JW
    Neurosci Lett; 1987 Apr; 75(3):323-8. PubMed ID: 3495754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity?
    Irwin I; Langston JW
    Life Sci; 1985 Jan; 36(3):207-12. PubMed ID: 3871240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central hypothermic effects of some analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium ion (MPP+).
    Satoh N; Yonezawa A; Tadano T; Kisara K; Arai Y; Kinemuchi H
    Neurosci Lett; 1987 Sep; 80(1):100-5. PubMed ID: 3498916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.